Showing results (371-380 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|November 4, 2015
Effect of low-fat diet interventions versus other diet interventions on long-term weight change in adults: a systematic review and meta-analysisDeirdre K Tobias, Mu Chen, JoAnn E Manson, et al.
The Lancet. Diabetes & Endocrinology|February 1, 2016
Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implicationsNorbert Stefan, Hans-Ulrich Häring, Frank B Hu, et al.
The Lancet. Diabetes & Endocrinology|October 3, 2015
Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort studyBjörn Eliasson, Vasileios Liakopoulos, Stefan Franzén, et al.
The Lancet. Diabetes & Endocrinology|October 3, 2015
Reduction of cardiovascular risk in chronic kidney disease by mineralocorticoid receptor antagonismMurray Epstein
The Lancet. Diabetes & Endocrinology|September 6, 2015
Efficacy, safety, and patient acceptability of Technosphere inhaled insulin for people with diabetes: a systematic review and meta-analysisAnastassios G Pittas, Gregory P Westcott, Ethan M Balk
The Lancet. Diabetes & Endocrinology|January 17, 2015
Iodine deficiency and thyroid disordersMichael B Zimmermann, Kristien Boelaert
The Lancet. Diabetes & Endocrinology|December 4, 2014
Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trialKatsuyuki Ando, Hiroshi Ohtsu, Shunya Uchida, et al.
The Lancet. Diabetes & Endocrinology|November 7, 2020
Guideline recommendations and the positioning of newer drugs in type 2 diabetes careNikolaus Marx, Melanie J Davies, Peter J Grant, et al.
The Lancet. Diabetes & Endocrinology|February 29, 2020
Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trialIda Pernicova, Stephen Kelly, Sharon Ajodha, et al.
The Lancet. Diabetes & Endocrinology|February 8, 2020
Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86)Ernesto Maddaloni, Ruth L Coleman, Olorunsola Agbaje, et al.
Pageof 93